IVBT OTC
Innovation1 Biotech Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$620K
+80.2% ▲
Capital Expenditures
$5
+99.8% ▲
5Y CAGR: -71.1%
Free Cash Flow
-$620K
+80.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$107K
-661.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$170K | -$3M | $1M | -$41M | -$6M |
| Depreciation & Amort. | $2K | $3K | $1K | $138K | $53K |
| Stock-Based Comp. | $19K | $0 | $0 | $0 | $103K |
| Change in Working Capital | -$156K | $702K | $257K | -$433K | $1M |
| Other Non-Cash Items | $51K | $1M | -$1M | $38M | $4M |
| Operating Cash Flow | -$776K | -$410K | -$30K | -$3M | -$620K |
| — Investing Activities — | |||||
| Capital Expenditures | -$7K | $0 | $0 | -$3K | -$5 |
| Acquisitions (Net) | $0 | $0 | $0 | -$850K | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$7K | -$300K | $0 | $0 | $5 |
| Investing Cash Flow | -$7K | -$300K | $0 | -$853K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $789K | $150K | $0 | $514K |
| Stock Repurchased | $0 | -$80K | $0 | $0 | $0 |
| Dividends Paid | -$27K | $0 | -$170K | $0 | $0 |
| Other Financing | $54K | $0 | $170K | $0 | $0 |
| Financing Cash Flow | $27K | $709K | $150K | $4M | $514K |
| Net Change in Cash | -$755K | -$1K | $120K | $19K | -$107K |
| Cash End of Period | $19K | $18K | $137K | $156K | $50K |
| Free Cash Flow | -$782K | -$410K | -$30K | -$3M | -$620K |